Xavier Durà-Miralles

Author

Also Known As

Aguilar-Company, J., Fortún J., X. Durà-Miralles, Xavier Durà-Miralles

Publications

291

Citations

H-Index

Concepts

All Affiliations

Xavier Durà-Miralles is an author at Bellvitge University Hospital specializing in antimicrobial therapy, clinical microbiology, and sepsis.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	13
2	Antibiotics	1	1	13
3	Antimicrobial Pharmacodynamics	1	1	13
4	Antimicrobial Pharmacokinetics	1	1	13
5	Clinical Microbiology	1	1	13

Xavier Durà-Miralles

Publications

284

Citations

H-Index

Page 1

	Year	Citations
Patterns of Long COVID Symptoms: A Multi-Center Cross Sectional Study Dana Yelin, Ili Margalit, Mayssam Nehme, Journal of Clinical Medicine	2022	75
Characteristics of long-COVID among older adults: a cross-sectional study Vered Daitch, Dana Yelin, Muhammad Awwad, International Journal of Infectious Diseases	2022	73
Impact of the Inclusion of an Aminoglycoside to the Initial Empirical Antibiotic Therapy for Gram-Negative Bloodstream Infections in Hematological Neutropenic Patients: a Propensity-Matched Cohort Study (AMINOLACTAM Study) Adaia Albasanz‐Puig, Carlota Gudiol, Pedro Puerta‐Alcalde, Antimicrobial Agents and Chemotherapy	2021	48
Co-infections and superinfections complicating COVID-19 in cancer patients: A multicentre, international study Carlota Gudiol, Xavier Durà-Miralles Journal of Infection	2021	46
Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study) Alba Bergas, Adaia Albasanz‐Puig, Ana Fernández‐Cruz, Microbiology Spectrum	2022	29
Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with Pseudomonas aeruginosa Pneumonia Adaia Albasanz‐Puig, Xavier Durà-Miralles, Júlia Laporte-Amargós, Microorganisms Antimicrobial ChemotherapyAntibiotic ResistanceNeutropenic Cancer PatientsAntimicrobial StewardshipPa Bsi	2022	13

Page 1